<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04061538</url>
  </required_header>
  <id_info>
    <org_study_id>1474</org_study_id>
    <nct_id>NCT04061538</nct_id>
  </id_info>
  <brief_title>Efficiency and Safety of Zinc Sulphate to Reduce the Duration of Acute Diarrheal Disease Between 6 and 59 Months of Age</brief_title>
  <acronym>ESZnDiarrhea</acronym>
  <official_title>Efficiency and Safety of Zinc Sulphate to Reduce the Duration of Acute Diarrheal Disease Between 6 and 59 Months of Age</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto Nacional de Salud Publica, Mexico</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>UNICEF</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Instituto Nacional de Salud Publica, Mexico</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the effect of zinc over the duration, severity and relapse of acute
      diarrheic disease, in children between 6 and 59 months of age. One study group will receive a
      tablet that contains 20 mg of zinc, and the other study group will receive a tablet,that does
      not contain zinc, it is a tablet that investigators will use as control.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In Mexico acute diarrheal diseases mortality in children continues to be a public health
      issue, being between the main causes of morbidity and mortality, with an important load for
      the health systems. Consequently, there exists a necessity for the implementation of
      alternate strategies for this condition, nutrition being one of the pillars to strengthen.

      Zinc administration during the diarrhea episode is a simple intervention for clinical picture
      reduction and relapse. The recommendation of including zinc in the treatment of ADD is not
      part of the Mexican normativity. The evaluation of the efficacy of zinc administration in
      Mexican children is insufficient and a program or national strategy for zinc treatment does
      not exist.

      The objective of this study is evaluates the efficacy of oral zinc sulfate administration,
      during the diarrhea clinic picture in children of Mexico City.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 9, 2017</start_date>
  <completion_date type="Actual">January 31, 2019</completion_date>
  <primary_completion_date type="Actual">September 14, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diarrhea duration</measure>
    <time_frame>10 days</time_frame>
    <description>Number of hours from the inclusion of the patient until the end of the diarrhea. The end of diarrhea was defined as the last diarrhea evacuation followed by a 48 hr period without diarrhea</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stool frequency</measure>
    <time_frame>10 days</time_frame>
    <description>Number of stools during during the acute diarrheic disease</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>diarrheic disease recurrence</measure>
    <time_frame>3 and 6 months</time_frame>
    <description>Number of acute diarrheal episode, after the first episode</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>zinc serum concentration</measure>
    <time_frame>3, 9, 20, 31, 61, 91 and 121 days</time_frame>
    <description>Difference of zinc serum concentration after the oral treatment for 10 days with 20 mg of zinc, and its correlation with the duration of diarrhea , the number of total stools and relapse rates</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">529</enrollment>
  <condition>Diarrhoea;Acute</condition>
  <condition>Diarrhea, Infantile</condition>
  <arm_group>
    <arm_group_label>Zinc sulfate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Zinc sulfate 20 mg by mouth, once a day for 10 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo tablet, once a day for 10 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>zinc sulfate</intervention_name>
    <description>zinc 20mg tablets</description>
    <arm_group_label>Zinc sulfate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Sugar pill manufactured to mimic zinc 20mg tablet</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Placebo (for zinc)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Both sexes

          -  Children attended in the sentinel centers

          -  Clinical diagnosis of acute diarrhea disease

          -  Parents have not planned moving to other location in a time period of at least one
             year.

        Exclusion Criteria:

          -  Deficient intestinal absorption syndrome

          -  Acrodermatitis enterohepatic

          -  Zinc sulfate hypersensitivity

          -  Leucine metabolic disorders

          -  Secondary lactose intolerance

          -  Galactosemia lactase primary deficiency

          -  Allergy to cow milk protein

          -  Children that are supplemented with zinc for the last 6 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>59 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jorge Salmeron, PHD</last_name>
    <role>Study Chair</role>
    <affiliation>Universidad Nacional Autonoma de Mexico</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Edgar Sanchez, McS</last_name>
    <role>Study Director</role>
    <affiliation>Universidad Nacional Autonoma de Mexico</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marcelino Esparza Aguilar, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Institute of Pediatrics in Mexico</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Pediatrico de Coyoacan</name>
      <address>
        <city>Mexico City</city>
        <zip>04000</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto Nacional de Pediatria</name>
      <address>
        <city>Mexico City</city>
        <zip>04530</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Pediatrico La Villa</name>
      <address>
        <city>Mexico City</city>
        <zip>07050</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Pediatrico de Iztapalapa</name>
      <address>
        <city>Mexico City</city>
        <zip>09070</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Pedi√°trico de Tacubaya</name>
      <address>
        <city>Mexico City</city>
        <zip>11870</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro de Salud Cultura Maya</name>
      <address>
        <city>Mexico City</city>
        <zip>14230</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro de Salud San Andres Totoltepec</name>
      <address>
        <city>Mexico City</city>
        <zip>14400</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro de Salud Topilejo</name>
      <address>
        <city>Mexico City</city>
        <zip>14500</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Materno Infantil de Xochimilco</name>
      <address>
        <city>Mexico City</city>
        <zip>16090</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>August 2, 2019</study_first_submitted>
  <study_first_submitted_qc>August 15, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 20, 2019</study_first_posted>
  <last_update_submitted>August 15, 2019</last_update_submitted>
  <last_update_submitted_qc>August 15, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Instituto Nacional de Salud Publica, Mexico</investigator_affiliation>
    <investigator_full_name>Jorge Salmeron Castro</investigator_full_name>
    <investigator_title>Honorary researcher</investigator_title>
  </responsible_party>
  <keyword>zinc sulfate</keyword>
  <keyword>Children</keyword>
  <keyword>acute diarrheal diseases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diarrhea</mesh_term>
    <mesh_term>Diarrhea, Infantile</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Zinc</mesh_term>
    <mesh_term>Zinc Sulfate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>May 22, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/38/NCT04061538/ICF_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 22, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/38/NCT04061538/Prot_SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

